MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Calcium Channel Blocking Drugs and Risk of LRRK2 Parkinson’s Disease

    C. Marras, K. Marder, R. Alcalay, R. Saunders-Pullman, C. Meng, S. Goldman, A. Lang, M. Korell, M. San Luciano, E. Tolosa, B. Schuele, A. Brice, S. Goldwurm, G. Riboldazzi, C. Klein, G. Mellick, C. Sue, E.K. Tan, K. Brockmann, K. Hasegawa, S. Bressman, J. Ferreira, M. Tazir, W. Langston, D. Berg, C. Tanner (Toronto, ON, Canada)

    Objective: To test the association between Parkinson’s disease (PD) and calcium channel blocker CCB use in individuals carrying LRRK2 mutations. Background: LRRK2 mutation penetrance is…
  • 2017 International Congress

    Increased BMI May Protect Against Parkinson’s Disease: Evidence From A Mendelian Randomisation Study

    A. Noyce, D. Kia, G. Hemani, A. Nicolas, T. Price, E. Fernandez, P. Haycock, P. Lewis, T. Foltynie, G. Davey Smith, A. Schrag, A. Lees, J. Hardy, A. Singleton, M. Nalls, N. Pearce, D. Lawlor, N. Wood (London, United Kingdom)

    Objective: To use two-sample Mendelian randomisation (MR) to study the causal effect of body mass index (BMI) on Parkinson's disease (PD). Background: Both positive and…
  • 2017 International Congress

    General Anesthesia and Parkinson’s Disease

    C.-W. CHEN, K.-B. CHEN, Y.-C. KUO (TAICHUNG, Taiwan)

    Objective: Postoperative cognitive dysfunction is common among the elderly. These changes may even be so severe that some elderly people actually become demented after undergoing…
  • 2017 International Congress

    Vascular Parkinsonism, an underdiagnosed Parkinsonian variant : An outpatient study from a South Indian Superspeciality Private Hospital

    S. Jaiswal, M. Reddy (Hyderabad, India)

    Objective: To study the prevalence of vascular parkinsonism (VP) in a general neurology outpatient department. Background: Prevalence of vascular parkinsonism (VP) in contemporary literature varied…
  • 2017 International Congress

    MDS prodromal PD research criteria validation in two independent prospective cohorts

    A. Pilotto, S. Heinzel, U. Suenkel, S. Lerche, K. Brockmann, b. Roeben, E. Schaeffer, i. Wurster, R. Yilmaz, I. Liepelt-Scarfone, A. von Thaler, F. Metzger, g. Eschweiler, R. Postuma, W. Maetzler, D. Berg (Tuebingen, Germany)

    Objective: To evaluate the Movement Disorder Society prodromal Parkinson's disease criteria to two independent longitudinal studies Background: The MDS research criteria for prodromal Parkinson’s disease (PD)…
  • 2017 International Congress

    Body mass index, change in body mass index and risk of Parkinson`s disease

    J. Lee, J.H. Kim, J.H. Cho, G.S. Kim, J.H. Lee, P.H. Lee, Y.H. Sohn (Goyang-shi, Republic of Korea)

    Objective:  Our aim is to show the association between BMI and risk of PD and to evaluate how change in BMI is associated with occurrence…
  • 2017 International Congress

    Is Hypertension and Certain Anti Hypertensive Agents Increase The Risk of Parkinson Disease?

    R. Pinzon (Yogyakarta, Indonesia)

    Objective: The aim of this study is measure the risk of PD related to hypertension and certain use of anti hypertensive treatment.   Background: Cardiovascular risk…
  • 2017 International Congress

    Helicobacter pylori eradication and risk of Parkinson’s disease in patients with peptic ulcers

    Y.-P. Chang, G.-F. Chiu, Y.-H. Chang, D.-C. Wu (Kaohsiung, Taiwan)

    Objective: To observe the effect of Helicobacter pylori eradication on the incidence of Parkinson's disease Background: The prevalence of Helicobacter pylori (H. pylori) is high in Parkinson's disease (PD)…
  • 2017 International Congress

    Serum cholesterol levels over time and risk of Parkinson’s disease

    V. Rozani, T. Gurevich, N. Giladi, B. El-Ad, J. Tsamir, B. Hemo, C. Peretz (Tel A viv, Israel)

    Objective: To evaluate the association of serum cholesterol levels over time with the risk of Parkinson's disease (PD); among statin-free individuals. Background: High levels of…
  • 2017 International Congress

    The Roles of Diet, Exercise, & Supplements in Parkinson’s Disease Progression

    L. Mischley, R. Lau (Kenmore, WA, USA)

    Objective: The goal of this ongoing study is to describe whether modifiable aspects of lifestyle are associated with PD symptom severity and progression. Background: Epidemiological…
  • « Previous Page
  • 1
  • …
  • 1582
  • 1583
  • 1584
  • 1585
  • 1586
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley